Vijaya Diagnostic Centre CFO resigns effective July 24, 2026

1 min read Updated on 10 Jun 2026, 04:03 AM

Reviewed by

Riya DScanX News Team

AI Summary

Vijaya Diagnostic Centre Limited announced the resignation of its Chief Financial Officer, Mr. Ankit Shah, effective on or before July 24, 2026, due to personal reasons. The company informed the exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Shah committed to ensuring a smooth transition and handing over pending responsibilities.

*this image is generated using AI for illustrative purposes only.

Vijaya Diagnostic Centre Limited disclosed that its Chief Financial Officer, Mr. Ankit Shah, has resigned from his position due to personal reasons. His departure is scheduled to take effect on or before July 24, 2026. The company acknowledged his contributions and expressed appreciation for his service during his tenure.

The resignation was intimated to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company referenced the detailed disclosure requirements outlined in SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

In his resignation letter addressed to the Board of Directors, Mr. Shah stated that he would assist in the handover of responsibilities to ensure a smooth transition. He committed to properly transferring all pending projects to the appropriate team members before his final departure.

The following table summarizes the key details regarding the change in the company's financial leadership:

Particulars	Details
Name of Official	Ankit Shah
Designation	Chief Financial Officer
Reason for Change	Resignation
Effective Date	On or before July 24, 2026

The communication was signed by Naga Vasudha Tadepalli, Company Secretary & Compliance Officer of Vijaya Diagnostic Centre Limited, on June 09, 2026.

Historical Stock Returns for Vijaya Diagnostic Centre

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.75%	-0.02%	+0.02%	+25.90%	+34.53%	+106.29%

Who will be appointed as the successor to Ankit Shah, and how will their background influence the company's financial strategy?

How might the extended timeline until July 2026 impact the company's ongoing financial projects and strategic planning?

Will the CFO transition lead to any shifts in Vijaya Diagnostic Centre's investment priorities or capital allocation?

Read Next Article

Vijaya Diagnostic Centre to host investor meet in Singapore

1 min read Updated on 10 Jun 2026, 03:53 AM

Reviewed by

Shriram SScanX News Team

Add as a preferred
source on Google

AI Summary

Vijaya Diagnostic Centre Limited will host a non-deal roadshow with Emkay Global Financial Services in Singapore on June 15 and June 16, 2026. The one-on-one meetings will focus on publicly available information without sharing unpublished price sensitive data. The schedule is subject to change based on exigencies.

*this image is generated using AI for illustrative purposes only.

Vijaya Diagnostic Centre Limited has scheduled a non-deal roadshow with institutional investors and analysts in Singapore on June 15 and June 16, 2026. The meeting aims to engage with market participants based on publicly available information, ensuring no unpublished price sensitive information is disclosed. This interaction provides stakeholders an opportunity to discuss the company's performance and outlook directly with its officials.

The meeting will be held with Emkay Global Financial Services in a one-on-one, in-person format. The sessions are scheduled to run from 09:00 A.M. to 06:00 P.M. IST on both days. The company noted that the schedule is subject to change due to exigencies on the part of the participants or the company.

Meeting Details

Date / Time of Meeting	Analysts / Institutional Investors / Organisation	Type / Mode of the Meeting	Venue of the Meeting
Monday, June 15, 2026 & Tuesday, June 16, 2026 from 09:00 A.M. to 06:00 P.M. (IST)	Emkay Global Financial Services (Non-Deal Roadshow)	One on One Meeting - In Person	Singapore

The company clarified that all discussions will be strictly based on information already available in the public domain. Investors and analysts may approach the company subsequently for any clarifications regarding the discussions held during the meeting. The disclosure was made to the National Stock Exchange of India Limited and BSE Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Vijaya Diagnostic Centre